星云体育(China)官方网站-Best App Store

Select Region / Language
Pioneering Diagnostic Solutions: Snibe's Highlights at WorldLab 2024
Events2024-05-29
share:

From May 26–30, the 26th International Congress of Clinical Chemistry and Laboratory Medicine (IFCC WorldLab 2024) took place at the Dubai World Trade Centre in Dubai, UAE. Snibe, attending as a platinum sponsor, presented its latest innovations and advanced laboratory solutions to a global audience.

image.png(83)_1717049730.jpeg

     

At the Snibe booth (#No. 8), Snibe displayed a comprehensive range of advanced diagnostic programs, including chemiluminescence, biochemistry, molecular diagnostics, and hemostasis. Among the highlights was the Biolumi CX10, an ultra-fast all-in-one product that merges the thousand-throughput capabilities of the MAGLUMI X10 with the efficient biochemical analysis of the Biossays C10.

lQDPJwRQ4kX3SxHNA3TNBJuwAtd1PaphjwgGP-A23TI9AA_1179_884_1717049736.jpeg

   

Snibe's diagnostic new products showcased at WorldLab 2024 also include:

Molesicion™R8: A fully automated molecular diagnostics system that completes the entire PCR testing process in one analyzer.

Molesicion™S6: A PCR system utilizing third-generation digital PCR technology to achieve absolute quantification by partitioning the reaction.

Hemolumi®H6: A dual-technology automated coagulation analyzer with high detection sensitivity, unaffected by hemolyzed, icteric, or lipemic samples.

image.png(84)_1717049734.jpeg

  

Additionally, the star product, MAGLUMI X3, was also showcased at the exhibition. MAGLUMI X3 has high throughput (200 tests/hour) and a small footprint (<0.68 m2). Based on its high spatial efficiency, it is more flexible and can meet the needs of different-sized hospitals and labs. 

切片1(15)_1717049734.jpeg

    

Snibe also hosted educational workshops, featuring top professors and doctors who provided insights into the latest in laboratory medicine. On May 27 and 29, internationally renowned experts delivered lectures in Room A, discussing hot topics and advanced research in the field. Snibe expresses sincere appreciation to all participants for their contributions and insights.  

image.png(87)_1717049726.jpeg

   

With 29 years of focus on in vitro diagnostics, Snibe's products are now available in over 155 countries and regions, with more than 30,000 installations globally. Snibe remains committed to delivering comprehensive services and high-quality products, aiming to advance global healthcare. Thank you for participating in WorldLab 2024. We look forward to seeing you next time!